MedTrace Logo

Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C

NCT01900886 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 263

Last updated 2013-07-17

No results posted yet for this study

Summary

Primary objective: Evaluate the prevalence of personality disorders in patients starting treatment for hepatitis C in the prison and determine their influence on the evolution of the disease.

Conditions

  • Hepatitis C, Chronic
  • Personality Disorders in Prison

Interventions

OTHER

Peginterferon alfa-2a

Treatment as usual clinical practice

DRUG

Ribavirin

Treatment as usual clinical practice

Sponsors & Collaborators

  • Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria

    lead OTHER

Principal Investigators

  • Andres Marco, Medicine · Centro Penitenciario de Hombres de Barcelona. Prisión Modelo

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2013-06-30
Completion
2013-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01900886 on ClinicalTrials.gov